These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7533865)

  • 21. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
    Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
    Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S; Pettit GR; Howe C; McCrady C
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
    Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of granulocyte-macrophage colony-stimulating factor on undifferentiated and mature acute myelogenous leukemia blast progenitors.
    Estrov Z; Park CH; Reading CL; Estey EH; Talpaz M; Kurzrock R; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Aug; 20(7):886-90. PubMed ID: 1628706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
    Wörmann B; Hiddemann W; Frisch J; Zühlsdorf M; Rottmann R; Boeckmann A; Reuter C; Freire EA; Innig G; Schulz G
    Behring Inst Mitt; 1991 Dec; (90):28-38. PubMed ID: 1801688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the protein kinase C inhibitor staurosporine on chemosensitivity to daunorubicin of normal and leukemic fresh myeloid cells.
    Laredo J; Huynh A; Muller C; Jaffrézou JP; Bailly JD; Cassar G; Laurent G; Demur C
    Blood; 1994 Jul; 84(1):229-37. PubMed ID: 7912555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
    Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M
    Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
    Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S; Wagemaker G; Souza LM; Tatarsky I
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
    J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A late phase II comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group].
    Masaoka T; Ogawa M; Yamada K; Kimura K; Ohhashi Y
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1995-2005. PubMed ID: 8215474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.